WO2023139605 - LYSIN POLYPEPTIDES AND COMPOSITIONS THEREOF AGAINST URINARY TRACT INFECTION CAUSED BY DRUG-RESISTANT GRAM- NEGATIVE BACTERIA
National phase entry is expected:
Publication Number
WO/2023/139605
Publication Date
27.07.2023
International Application No.
PCT/IN2023/050059
International Filing Date
19.01.2023
Title **
[English]
LYSIN POLYPEPTIDES AND COMPOSITIONS THEREOF AGAINST URINARY TRACT INFECTION CAUSED BY DRUG-RESISTANT GRAM- NEGATIVE BACTERIA
[French]
POLYPEPTIDES DE LYSINE ET COMPOSITIONS DE CEUX-CI CONTRE UNE INFECTION DES VOIES URINAIRES PROVOQUÉE PAR DES BACTÉRIES À GRAM NÉGATIF RÉSISTANTES AUX MÉDICAMENTS
Applicants **
TECHINVENTION LIFECARE PVT. LTD.
1004, The Summit Business Park, Off WEH Metro Station, Andheri Kurla Road, Andheri (E)
Mumbai 400093, IN
BIOGRIT TECHNOLOGIES INC
Toronto Business Development Center, 325 Front Street West, Suite 300, Toronto, ON M5V 2Y1
Toronto, CA
Inventors
SYED, Ahmed S
Techinvention Lifecare Pvt Ltd
The Summit Business Bay (Omkar), #1004, Andheri - Kurla Rd, Gundavali, Andheri East
Mumbai 400093, IN
SYED, Safia
Techinvention Lifecare Pvt Ltd
The Summit Business Bay (Omkar), #1004, Andheri - Kurla Rd, Gundavali, Andheri East
Mumbai 400093, IN
HANIF, Sarmad
Techinvention Lifecare Pvt Ltd
The Summit Business Bay (Omkar), #1004, Andheri - Kurla Rd, Gundavali, Andheri East
Mumbai 400093, IN
BAJPAI, Urmi
Techinvention Lifecare Pvt Ltd
The Summit Business Bay (Omkar), #1004, Andheri - Kurla Rd, Gundavali, Andheri East
Mumbai 400093, IN
DAS, Ritam
Techinvention Lifecare Pvt Ltd
The Summit Business Bay (Omkar), #1004, Andheri - Kurla Rd, Gundavali, Andheri East
Mumbai 400093, IN
CHAVAN, Bhakti
Techinvention Lifecare Pvt Ltd
The Summit Business Bay (Omkar), #1004, Andheri - Kurla Rd, Gundavali, Andheri East
Mumbai 400093, IN
Priority Data
202221003315
20.01.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1035 | |
| EPO | Filing, Examination | 6548 | |
| Japan | Filing | 592 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3235 |
Total: 11985 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention provides a lysin polypeptide comprising an amino acid sequence having at least 80% or at least 85% or at least 90% or at least 95% identity to a sequence selected from the group consisting of SEQ ID NO: 1-SEQ ID NO: 16, or a fragment thereof having lysin activity. The present invention also provides a composition for prophylaxis and/or treatment of infections caused by Gram Negative Bacteria, the composition of lysin polypeptide comprising an amino acid sequence having at least 80% or at least 85% or at least 90% or at least 95% identity to a sequence selected from the group consisting of SEQ ID NO: 1-SEQ ID NO: 16, or a fragment thereof having lysin activity.[French]
La présente invention concerne un polypeptide de lysine comprenant une séquence d'acides aminés ayant au moins 80 % ou au moins 85 % ou au moins 90 % ou au moins 95 % d'identité avec une séquence choisie dans le groupe constitué par SEQ ID NO:1-SEQ ID NO:16, ou un fragment de celle-ci ayant une activité de lysine. La présente invention concerne également une composition pour la prophylaxie et/ou le traitement d'infections provoquées par des bactéries à Gram Négatif, la composition de polypeptide de lysine comprenant une séquence d'acides aminés ayant au moins 80 % ou au moins 85 % ou au moins 90 % ou au moins 95 % d'identité avec une séquence choisie dans le groupe constitué par SEQ ID NO:1-SEQ ID NO:16, ou un fragment de celle-ci ayant une activité de lysine.